Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Related Posts
Gupta S, Gee MM, Newton AJH, Kuttippurathu L, Moss A, Tompkins JD, Schwaber JS, Vadigepalli R, Lytton WW. Biophysical modelling of intrinsic cardiac nervous system[...]
Rousseau JF, Weber JM, Alhanti B, Saver JL, Messé SR, Schwamm LH, Fonarow GC, Sheth KN, Smith EE, Mullen MT, Silva GS, Mac Grory B,[...]
Kaur M, Katz R, Criqui MH, Corr M, Post WS, Budoff M, Morris GP, Hughes-Austin JM. Associations of HLA-DRB1 shared epitope alleles with cardiovascular disease[...]